HATBORO, Pa., Nov. 10, 2015 /PRNewswire/ -- We have valued our close working relationship with Valeant and are deeply disappointed that is has come to an end. It is unfortunate that this outcome was influenced by market forces, media misperceptions, and inflammatory, patently false reports by discredited short-sellers.
We particularly regret the impact these circumstances will have on our loyal employees, who have behaved ethically and in keeping with the highest business standards. We are extremely grateful for their hard work, dedication, and unflappable positivity in the face of difficult circumstances. As we have previously stated, Philidor's sole focus is and always has been providing patients the medication their doctors say they need quickly and efficiently.
We will continue to work closely with our regulators and payors, as we have done since commencing operations, to address any outstanding inquiries.
Contact:
Ron Hutchenson, [email protected]
Patrick Ryan, [email protected], 202-412-9596
Logo - http://photos.prnewswire.com/prnh/20151110/285977LOGO
SOURCE Philidor Rx Services
Share this article